High-performance liquid chromatography method for the quantification of entacapone in human plasma

Treatment of Parkinson's disease.

R Hardie · PubMed · 1985 · 217 citations

Medicine, Neurology, Pharmacotherapy +11

Treatment of Parkinson's Disease

New England Journal of Medicine · 1993 · 185 citations

Life Sciences, Neurology, Neuroscience +17

A Double-Blind Pharmacokinetic and Clinical Dose—Response Study of Entacapone as an Adjuvant to Levodopa Therapy in Advanced Parkinson's Disease

Hanna Ruottinen, U. K. Rinne · Clinical Neuropharmacology · 1996 · 127 citations

Medicine, Pharmacology, Pharmacotherapy +17

Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans.

Tom Wikberg, Annamari Vuorela, Pekka Ottoila et al. · Drug Metabolism and Disposition · 1993 · 89 citations

Life Sciences, Biochemistry, Pharmacology +16

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease

V. V. Myllyl�, K. A. Sotaniemi, Ari Illi et al. · European Journal of Clinical Pharmacology · 1993 · 83 citations

Medicine, Pharmacokinetics, Pharmacology +13